Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Katie Hsu"'
Autor:
Magdiel Pérez-Cruz, Bettina P. Iliopoulou, Katie Hsu, Hsin-Hsu Wu, Tom Erkers, Kavya Swaminathan, Sai-Wen Tang, Cameron S. Bader, Neeraja Kambham, Bryan Xie, Rosemarie H. Dekruyff, Gordon J. Freeman, Everett Meyer
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Graft-versus-host disease (GvHD) is a major complication after allogeneic hematopoietic cell transplantation (HCT). Current strategies to prevent GvHD with immunosuppressive drugs carry significant morbidity and may affect the graft-versus-tumor (GVT
Externí odkaz:
https://doaj.org/article/52d810967da849ec81e0eb878c3f5f63
Autor:
Bettina P. Iliopoulou, Katie Hsu, Magdiel Pérez-Cruz, Sai-Wen Tang, Wendy W. Pang, Tom Erkers, Neeraja Kambham, Gordon J. Freeman, Rosemarie H. Dekruyff, Everett H. Meyer
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3419-3431 (2019)
Abstract: Acute graft-versus-host disease (GVHD) is a leading cause of mortality after allogeneic hematopoietic cell transplantation (HCT) mediated by dysregulated T-cell immune reconstitution. Given the role of the T-cell immunoglobulin and mucin 1
Externí odkaz:
https://doaj.org/article/7c367ff509bc4256af1f523813efd29e
Autor:
Tod Harper, Amy Sharma, Sarav Kaliyaperumal, Flordeliza Fajardo, Katie Hsu, Lily Liu, Rhian Davies, Yu-Ling Wei, Jinghui Zhan, Juan Estrada, Majk Kvesic, Lisa Nahrwold, Wibke Deisting, Marc Panzer, Keegan Cooke, Hervé Lebrec, Olivier Nolan-Stevaux
Publikováno v:
Toxicological Sciences. 189:32-50
Bispecific T-cell engager (BiTE) molecules have great potential to treat cancer. Nevertheless, dependent on the targeted tumor antigen, the mechanism of action that drives efficacy may also contribute to on-target/off-tumor toxicities. In this study,
Autor:
Rebecca Goldstein, Christine Karbowski, Anja Henn, Petra Deegen, Joachim Wahl, Katja Matthes, Christoph Dahlhoff, Brooke Rock, Sabrina Benchaar, Katie Hsu, Brandy Alexander, Matthias Friedrich, Joan Lane, Xiaoting Wang, Jonas Anlahr, Markus Muenz, Tobias Raum, Tara L. Arvedson
Publikováno v:
Cancer Research. 82:6313-6313
Acute myeloid leukemia is a grievous illness. BiTE® (bispecific T cell engager) molecules redirect T cells by engaging CD3 and a tumor-associated antigen (TAA). These molecules have shown clinical efficacy but one mechanism of resistance is loss of
Autor:
Rosemarie H. DeKruyff, Katie Hsu, Wendy W. Pang, Bettina P. Iliopoulou, Neeraja Kambham, Everett Meyer, Magdiel Pérez-Cruz, Tom Erkers, Sai-Wen Tang, Gordon J. Freeman
Acute graft-versus-host disease (GVHD) is a leading cause of mortality after allogeneic hematopoietic cell transplantation (HCT) mediated by dysregulated T-cell immune reconstitution. Given the role of the T-cell immunoglobulin and mucin 1 (TIM-1) su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63f9bbda21c322c998c28bdff2519db
https://europepmc.org/articles/PMC6855109/
https://europepmc.org/articles/PMC6855109/
Autor:
Elizabeth A. Eklund, Kathleen M. Sakamoto, Nick Cox, Bruce Tiu, Bryan Mitton, Kevin G. McLure, Katie Hsu, Ritika Dutta, Hee-Don Chae, Mark Smith, David E. Solow-Cordero
Publikováno v:
Oncotarget
// Bryan Mitton 1 , Katie Hsu 1 , Ritika Dutta 1 , Bruce C. Tiu 1 , Nick Cox 2 , Kevin G. McLure 1 , Hee-Don Chae 1 , Mark Smith 2 , Elizabeth A. Eklund 3 , David E. Solow-Cordero 4, * , Kathleen M. Sakamoto 1, * 1 Department of Pediatrics, Stanford
Autor:
William Strober, Bettina P. Iliopoulou, Antonio Pierini, Andrea Velardi, Magdiel Pérez-Cruz, Sai-Wen Tang, Aaron M. Ring, Tom Erkers, Xueying Gu, Everett Meyer, Jeanette Baker, Robert S. Negrin, Heshan Peiris, Katie Hsu, Maite Alvarez, Pingping Zheng, Seung K. Kim
Publikováno v:
JCI Insight. 2
Cellular therapies based on permanent genetic modification of conventional T cells have emerged as a promising strategy for cancer. However, it remains unknown if modification of T cell subsets, such as Tregs, could be useful in other settings, such
Autor:
Andrea Velardi, Seung K. Kim, Tom Erkers, Antonio Pierini, Magdiel Perez Cruz, Pingping Zheng, Everett Meyer, Heshan Peiris, Jeanette Baker, Robert S. Negrin, Aaron M. Ring, Bettina P. Iliopoulou, Katie Hsu, William Strober
INTRODUCTION Regulatory T cells (Treg) modulate allograft immune responses and Treg-based cellular therapies can be used for prevention of graft-versus-host disease (GvHD) following hematopoietic cell transplantation and for prevention of allograft r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::719ac15f4c8ac668e866047c2fe834b7
http://hdl.handle.net/11391/1430901
http://hdl.handle.net/11391/1430901
Autor:
Katie Hsu, Gordon J. Freeman, Rosemarie H. DeKruyff, Antonio Pierini, Bettina P. Iliopoulou, Everett Meyer
Graft-versus-host disease (GVHD) continues to be a common cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). The T cell immunoglobulin and mucin (TIM) proteins represent a family of molecules that act in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854a118b1961c21e57789e8e36818fc4
http://hdl.handle.net/11391/1430235
http://hdl.handle.net/11391/1430235
Autor:
Everett Meyer, John S. Tamaresis, Robert S. Negrin, James L. Zehnder, Bettina P. Iliopoulou, Antonio Pierini, Raj Than, Liwen Xu, Katie Hsu, Xiaoqing You, Pingping Zheng, Dominik Schneidawind, Bruce R. Blazar
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S307-S308